Skip to content

HERE: Health Empowerment and Resources After Pregnancy

HERE: Health Empowerment and Resources After Pregnancy A Pilot Randomized Controlled Trial of Patient Navigation to Improve Linkage to Primary Care After Hypertensive Disorders of Pregnancy

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07701148
Acronym
HERE
Enrollment
60
Registered
2026-07-14
Start date
2026-09-01
Completion date
2028-09-01
Last updated
2026-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Health

Keywords

Community wellness advocate, Remote blood pressure monitoring, Postpartum, Hypertensive disorders of pregnancy

Brief summary

This study will examine whether a patient navigation program can help improve long-term heart health among people who experienced high blood pressure disorders during pregnancy at Boston Medical Center (BMC). Conditions such as preeclampsia and other hypertensive disorders of pregnancy increase a person's risk of developing cardiovascular disease later in life. However, many patients do not receive timely follow-up care after pregnancy, especially once routine postpartum care ends. about 60 participants will be randomly assigned to one of two groups. One group will receive standard care, which includes clinician-directed counseling about cardiovascular risk and recommendations for follow-up care. The other group will receive support from a patient navigator in addition to standard care. Patient navigators, also known as Community Wellness Advocates (CWAs), are trained staff who help patients connect with health services, understand their health risks, and navigate the healthcare system. The main goals of the study are to determine whether this navigation program is practical to implement and acceptable to patients and healthcare providers. Researchers will also examine whether the program improves follow-up with primary care, cardiovascular risk assessment, and engagement in heart-healthy behaviors. Information will be collected from medical records, surveys, and interviews with participants and healthcare staff. Participants will be followed for one year

Interventions

OTHERLongitudinal patient navigation

A Community Wellness Advocate (CWA) will provide longitudinal patient navigation-proactive check-ins, assistance with appointment attendance scheduling and planning, identification of barriers to care, follow-up after missed appointments, mental health and social needs screening, and connections to appropriate resources. The CWA will serve as a consistent point of contact throughout the postpartum year.

OTHERStandard care

Standard care includes education on postpartum hypertension, a blood pressure cuff for self-monitoring, and assistance with scheduling follow-up care, including referral to a postpartum bridge clinic in General Internal Medicine.

Sponsors

Boston Medical Center
Lead SponsorOTHER
National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
23 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Gave birth at Boston Medical Center (BMC) in the past 2 months * Diagnosis of ≥1 hypertensive disorder of pregnancy during their most recent pregnancy * Active prescription for ≥1 antihypertensive medication * Scheduled for follow-up in the postpartum bridge clinic at BMC * Planning to continue using Boston Medical Center for their health care * Able and willing to provide informed consent and contact information in English, Spanish, or Haitian Creole (CWA will use hospital interpreter services as needed to communicate with patients with a language preference other than English)

Exclusion criteria

* Diagnosed with cardiovascular disease * Planning pregnancy in next 3 months * Planning to move out of Massachusetts within the postpartum year

Design outcomes

Primary

MeasureTime frameDescription
Acceptability of the intervention4-6 and 12 months postpartumAcceptability, the perception among stakeholders that the intervention is agreeable, will be measured using the 4-item Acceptability of Intervention Measure. Responses will be collected on a 5-point Likert scale (1-5), and the total score will range from 4-20. Total score will be evaluated as a continuous outcome with higher scores indicating greater acceptability. Results will be separately analyzed among participants, navigators, and other clinical staff.
Feasibility of the intervention4-6 and 12 months postpartumFeasibility, the extent to which the intervention can be carried out, will be measured using the 4-item Feasibility of Intervention Measure. Responses will be collected on a 5-point Likert scale (1-5), and the total score will range from 4-20. Total score will be evaluated as a continuous outcome with higher scores indicating greater feasibility.
Fidelity of the intervention- Penetrationmonthly for 12 months postpartumPenetration or "reach" is defined as the percentage of eligible individuals who were screened. This fidelity related metric will be assessed using a protocol-based checklist and electronic health record data for reference monthly
Fidelity of the intervention- Adherencemonthly for 12 months postpartumAdherence is defined as the percentage of enrolled participants who were supported by the navigator. This fidelity related metric will be assessed using a protocol-based checklist and electronic health record data for reference monthly.

Secondary

MeasureTime frameDescription
Participation Satisfaction4-6 and 12 months postpartumSatisfaction will be measured using the 18-item Patient Satisfaction Questionnaire (PSQ-18). Each item is rated on a 5-point Likert scale (strongly agree to strongly disagree), and items are grouped into 7 dimensions of care: general satisfaction, technical quality, interpersonal manner, communication, financial aspects, time spent with doctor, and accessibility and convenience. Each dimension is measured by 2-4 items. After reverse-coding negatively worded items, we will calculate the mean response score (1-5) for each dimension, with higher scores indicating greater satisfaction with care.
Linkage to Primary Care4-6 and 12 months postpartumThe measure will be the percentage of participants with a completed primary care visit, excluding Bridge clinic appointments, occurring between \>6 weeks and 1 year postpartum.
Cardiovascular Health (CVH)2, 4-6, and 12 months postpartumCVH will be defined using the American Heart Association's Life's Essential 8 construct, which scores each of 8 domains from 0 to 100 and generates an overall CVH score as the unweighted average of the 8 component scores (0 = worst, 100 = best heart health). The 8 components of CVH are- diet, physical activity, sleep, nicotine exposure, body mass index, blood lipids, blood glucose, and blood pressure. Diet, physical activity, sleep, and nicotine exposure will be assessed by self-report via survey. Body mass index, blood lipids, blood glucose, and blood pressure will be drawn from the electronic health record (using values closest to the assessment window), and EHR-documented tobacco use will corroborate self-reported nicotine exposure. Each domain subscore (0-100) will be calculated per Life's Essential 8 and generate the overall CVH score as the unweighted average of the 8 domains.
Cardiovascular Disease (CVD) Risk Assessment12 months postpartumCardiovascular disease risk assessment will be defined as completion of both glycemic control testing (OGTT or A1c) and lipids testing between \>6 weeks and 1 year postpartum. This will be assessed from the electronic health record based on completed lab testing.
Patient Activation2, 4-6, and 12 months postpartumPatient activation, a composite measure of knowledge, skills, and confidence to become actively engaged in one's own health care, will be assessed using the 10-item Consumer Health Activation Index (CHAI). Scores range from 0-100 and are categorized as follows: 0-79 = Low activation; 80-94 = Moderate activation; 95-100 = High activation.
Bridge Clinic Attendance2, 4-6, and 12 months postpartumThe measure will be the percentage of participants with a completed bridge clinic appointment between \>6 weeks and 4 months postpartum.
CVD risk perception2, 4-6, and 12 months postpartumParticipants will be asked about their level of concern for their future heart health, on a 4-point scale. Descriptive statistics will be calculated on this outcome as an ordered categorical variable.

Countries

United States

Contacts

CONTACTMara Murray Horwitz, MD, MPH
mara.murrayhorwitz@bmc.org617 638 8034
CONTACTRuth Rodriguez, BS
ruth.rodriguez2@bmc.org
PRINCIPAL_INVESTIGATORMara Murray Horwitz, MD, MPH

Boston Medical Center, General Internal Medicine

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 15, 2026